3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
18
Phase 3
6
Phase 1/2
4
Phase 1
4
Phase NA
3
Phase 4
2
Status
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
NETWORK
1
Study Type
Interventional
3
Sponsor
Cancer Type
Genitourinary
3
Conditions
Breast Neoplasms
3856
Neoplasms
2988
Prostatic Neoplasms
1751
Colorectal Neoplasms
1426
Lung Neoplasms
1327
Motor Activity
802
Head and Neck Neoplasms
683
Pancreatic Neoplasms
662
Colonic Neoplasms
655
Uterine Cervical Neoplasms
648
Carcinoma, Non-Small-Cell Lung
629
Carcinoma, Hepatocellular
628
Rectal Neoplasms
569
Stomach Neoplasms
544
Brain Neoplasms
483
Ovarian Neoplasms
438
Anxiety Disorders
419
Pain
418
Neoplasm Metastasis
385
Esophageal Neoplasms
384
Polycystic Ovary Syndrome
374
Precursor Cell Lymphoblastic Leukemia-Lymphoma
354
Urinary Bladder Neoplasms
351
Fatigue
339
Melanoma
322
Multiple Myeloma
320
Lymphoma
305
Depression
305
Endometrial Neoplasms
289
Liver Neoplasms
279
Interventions
Radiosurgery
2
Standard of Care
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Gonadotropin-Releasing Hormone
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase NA
×
Interventional
×
Prostate Cancer Metastatic
×
Clear all
NCT03784755
2026-03-27
PLATON
Canadian Cancer Trials Group
Phase NA
Active not recruiting
409 enrolled
NCT04983095
2026-02-17
METRO
Umeå University
Phase NA
Recruiting
118 enrolled
NCT05078151
2021-10-14
iPROMET
Vall d'Hebron Institute of Oncology
Phase NA
Unknown
69 enrolled